Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Kagan

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
Expert Review of Proteomics|November 20, 2015
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verificationHui Wang, Tujin Shi, Wei-Jun Qian, et al.
Molecular and Clinical Oncology|October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American menJames Farrell, Denise Young, Yongmei Chen, et al.
Clinical Chemistry|November 30, 2012
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkersZiding Feng, Jacob Kagan, Margaret Pepe, et al.
Urologic Oncology|July 31, 2004
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncologyWilliam E Grizzle, O John Semmes, Joseph Basler, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.
Genes & Cancer|September 16, 2014
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancerAnshu Rastogi, Shyh-Han Tan, Ahmed A Mohamed, et al.
Proteomics|May 3, 2008
Immobilization strategies for single-chain antibody microarraysShannon L Seurynck-Servoss, Cheryl L Baird, Keith D Miller, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
Expert Review of Proteomics|November 20, 2015
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verificationHui Wang, Tujin Shi, Wei-Jun Qian, et al.
Molecular and Clinical Oncology|October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American menJames Farrell, Denise Young, Yongmei Chen, et al.
Clinical Chemistry|November 30, 2012
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkersZiding Feng, Jacob Kagan, Margaret Pepe, et al.
Urologic Oncology|July 31, 2004
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncologyWilliam E Grizzle, O John Semmes, Joseph Basler, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.
Genes & Cancer|September 16, 2014
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancerAnshu Rastogi, Shyh-Han Tan, Ahmed A Mohamed, et al.
Proteomics|May 3, 2008
Immobilization strategies for single-chain antibody microarraysShannon L Seurynck-Servoss, Cheryl L Baird, Keith D Miller, et al.
Pageof 5